Factors Associated with Hypertension Awareness, Treatment, and Control in a Representative Sample of the Chinese Population

Hypertension

Volumn 43, Issue 3, 2004, Pages 578-585

  Muntner, Paul ^a,b,c   Gu, Dongfeng ^d   Wu, Xiqui ^d   Duan, Xiufang ^d   Wenqi, Gan ^d   Whelton, Paul K ^a,b,c   He, Jiang ^a,b,c  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Cross sectional studies; Hypertension, detection and control; Population

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; AWARENESS; BEHAVIOR MODIFICATION; BLOOD PRESSURE MEASUREMENT; CHINA; CHINESE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCOME; LIFESTYLE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PATIENT EDUCATION; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AWARENESS; BLOOD PRESSURE; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK REDUCTION BEHAVIOR; SOCIOECONOMIC FACTORS;

EID: 1442263892     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000116302.08484.14     Document Type: Article

References (30)

1. Yusuf S, Reddy S, Ounpuu S, and Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104: 2746-2753.
2. Murray CJL and Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston, MA: Harvard School of Public Health, World Health Organization, World Bank, 1996.
3. World Health Statistics Annual. Geneva, Switzerland: World Health Organization; 1998.
4. Roccella EJ, Bowler AE. Hypertension as a risk factor. Cardiovasc Clin. 1990;20:49-63.
5. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet. 1998;352:1801-1807.
6. The World Health Report. Making a difference. 1999.
7. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, Huang G, Reynolds RF, Su S, Whelton PK, and He J. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension. 2002;40: 920-927.
8. Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol. 1995;52:39-44.
9. Reynolds K, Gu D, Muntner P, Wu X, Chen J, Huang G, Duan X, Whelton PK, He J. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens. 2003;21: 1273-1281.
10. He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, and Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002;162:1051-1058.
11. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
12. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med. 1992;327:776-781.
13. Ainsworth BE, Haskell WL, Leon AS, Jacobs Jr DR, Montoye HJ, Sllis JF, Paffenbarger Jr RS. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25:71-80.
14. Perloff D, Grim CE, Flack, JM, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88:2460-2470.
15. StataCorp. STATA Statistical Software. 1999; Release 6.0.
16. Whelton PK, Appel LJ, Espeland MA, Applegate WB, Ettinger WH Jr., Kostis JB, Kumanyika S, Lacy CR, Johnson KC, Folmar S, Cutler JA. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998;279:839-846.
17. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA. 2002;288:1882-1888.
18. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA. 1997;277:1624-1632.
19. Xin X, He J, Frontini MG, Ogden LG, Motsamai OI, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112-1117.
20. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002;136:493-503.
21. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
22. McDowell A, Engle A, Massey JT, Maurer K. Plan and operation of the Second National Health and Nutrition Examination Survey 1976-1980. Vital Health Statistics. 1981;15:1-144.
23. National Center for Health Statistics. Plan and operation of the third national health and nutrition examination survey, 1988-1994. US Dept of Health and Human Services publication 94-1308.1994; 1.
24. Hajjar IM, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003; 290:199-206.
25. Nieto FJ, Alonso J, Chambless LE, Zhong M, Ceraso M, Romm FJ, Cooper L, Folsom, AR, Szklo M. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study. Arch Intern Med. 1995;155:677-684.
26. Banegas JR, Rodriguez-Artalejo F, de la Cruz Troca JJ, Guallar-Castillon P, del Rey Calero J. Blood pressure in Spain: distribution, awareness, control, and benefits of a reduction in average pressure. Hypertension. 1998;32:998-1002.
27. Ibrahim MM, Rizk H, Appel LJ, el Aroussy W, Helmy S, Sharaf Y, Ashour Z, Kandil H, Roccella E, Whelton PK. Hypertension prevalence, awareness, treatment, and control in Egypt. results from the Egyptian National Hypertension Project (NHP). NHP Investigative Team. Hypertension. 1995;26:886-890.
28. De Backer G, Myny K, De Henauw S, Doyen Z, Van Oyen H, Tafforeau J, Kornitzer M. Prevalence, awareness, treatment and control of arterial hypertension in an elderly population in Belgium. J Hum Hypertens. 1998;12:701-706.
29. Lang T. Factors that appear as obstacles to the control of high blood pressure. Ethnicity Disease. 2000;10:125-130.
30. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151-184.